AI Insight
This study developed and validated sustainable spectrophotometric methods for simultaneously measuring gliclazide (an antidiabetic medication) and its degradation product, Impurity A, which forms under alkaline conditions. The researchers employed spectrum manipulation techniques and multi-color analytical profile assessment to create stability-indicating analytical methods that can detect and quantify both the parent drug and its alkaline degradation impurity without requiring chromatographic separation.
Why it matters
These methods provide pharmaceutical quality control laboratories with cost-effective, environmentally friendly alternatives to traditional chromatographic techniques for monitoring gliclazide stability and purity. The ability to detect alkaline degradation products is crucial for ensuring medication safety and shelf-life determination in pharmaceutical manufacturing and storage.
Understand the Science